BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21749045)

  • 1. Synthesis and evaluation of novel gonadotropin-releasing hormone receptor-targeting peptides.
    Guo H; Lu J; Hathaway H; Royce ME; Prossnitz ER; Miao Y
    Bioconjug Chem; 2011 Aug; 22(8):1682-9. PubMed ID: 21749045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of D-phenylalanine enhanced the receptor binding affinities of gonadotropin-releasing hormone peptides.
    Lu J; Hathaway HJ; Royce ME; Prossnitz ER; Miao Y
    Bioorg Med Chem Lett; 2014 Feb; 24(3):725-30. PubMed ID: 24418777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging.
    Guo H; Gallazzi F; Sklar LA; Miao Y
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5184-7. PubMed ID: 21821417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of hydrocarbon linkers on the receptor binding affinities of gonadotropin-releasing hormone peptides.
    Guo H; Hathaway H; Royce ME; Prossnitz ER; Miao Y
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5484-7. PubMed ID: 24018188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of novel
    Xu J; Feng C; Miao Y
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4647-4651. PubMed ID: 28917649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Evaluation of
    Huang S; Li H; Han Y; Fu L; Ren Y; Zhang Y; Li Y; Sun P; Wang M; Wu H; Wang Q; Hu K
    Contrast Media Mol Imaging; 2019; 2019():5635269. PubMed ID: 30983920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
    Wild D; Wicki A; Mansi R; Béhé M; Keil B; Bernhardt P; Christofori G; Ell PJ; Mäcke HR
    J Nucl Med; 2010 Jul; 51(7):1059-67. PubMed ID: 20595511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody.
    Li L; Olafsen T; Anderson AL; Wu A; Raubitschek AA; Shively JE
    Bioconjug Chem; 2002; 13(5):985-95. PubMed ID: 12236780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas.
    Kumar SR; Quinn TP; Deutscher SL
    Clin Cancer Res; 2007 Oct; 13(20):6070-9. PubMed ID: 17947470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of an
    Kimura H; Fujita N; Kanbe K; Matsuda H; Watanabe H; Arimitsu K; Fujimoto H; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
    Bioorg Med Chem; 2017 Oct; 25(20):5772-5778. PubMed ID: 28927802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Neuropeptide Y1 Receptor for Cancer Imaging by Positron Emission Tomography Using Novel Truncated Peptides.
    Zhang C; Pan J; Lin KS; Dude I; Lau J; Zeisler J; Merkens H; Jenni S; Guérin B; Bénard F
    Mol Pharm; 2016 Nov; 13(11):3657-3664. PubMed ID: 27669056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of new GnRH-I receptor radionuclide therapy with
    Zoghi M; Attar Nosrati S; Rogni F; Shirvani G; Johari Daha F
    J Labelled Comp Radiopharm; 2019 Jun; 62(7):310-320. PubMed ID: 31033025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.
    Kumar SR; Deutscher SL
    J Nucl Med; 2008 May; 49(5):796-803. PubMed ID: 18413389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glucose-dependent insulinotropic polypeptide receptor: a novel target for neuroendocrine tumor imaging—first preclinical studies.
    Gourni E; Waser B; Clerc P; Fourmy D; Reubi JC; Maecke HR
    J Nucl Med; 2014 Jun; 55(6):976-82. PubMed ID: 24744444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging.
    Miao Y; Gallazzi F; Guo H; Quinn TP
    Bioconjug Chem; 2008 Feb; 19(2):539-47. PubMed ID: 18197608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Radiolabeling, and Preclinical Evaluation of
    Okarvi SM; Al-Jammaz I
    Cancer Biother Radiopharm; 2022 Jun; 37(5):372-383. PubMed ID: 35325547
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
    Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR
    J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.
    Guo H; Yang J; Gallazzi F; Prossnitz ER; Sklar LA; Miao Y
    Bioconjug Chem; 2009 Nov; 20(11):2162-8. PubMed ID: 19817405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display.
    Larimer BM; Thomas WD; Smith GP; Deutscher SL
    Mol Imaging Biol; 2014 Aug; 16(4):449-58. PubMed ID: 24550054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.